FDA Updates Warnings for Fluoroquinolone Antibiotics

Drug Industry Daily
A A
The FDA on Tuesday announced that it will strengthen current warnings in the prescribing information for fluoroquinolone antibiotics regarding potential mental health side effects and blood sugar disturbances.

To View This Article:

Login

Subscribe To Drug Industry Daily